Role of community empowerment in the elimination of lymphatic filariasis in south India.
Identifieur interne : 005640 ( Main/Exploration ); précédent : 005639; suivant : 005641Role of community empowerment in the elimination of lymphatic filariasis in south India.
Auteurs : R. Rajendran [Inde] ; I P Sunish ; A. Munirathinam ; V. Ashok Kumar ; B K TyagiSource :
- Tropical biomedicine [ 0127-5720 ] ; 2010.
Descripteurs français
- KwdFr :
- Albendazole (administration et posologie), Albendazole (effets indésirables), Albendazole (usage thérapeutique), Antihelminthiques (administration et posologie), Antihelminthiques (effets indésirables), Antihelminthiques (usage thérapeutique), Association de médicaments, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (effets indésirables), Diéthylcarbamazine (usage thérapeutique), Facteurs temps, Femelle, Filariose lymphatique (), Filariose lymphatique (épidémiologie), Humains, Inde (épidémiologie), Lutte contre les moustiques (), Participation communautaire, Services de santé communautaires (organisation et administration), Sol (parasitologie).
- MESH :
- administration et posologie : Albendazole, Antihelminthiques, Diéthylcarbamazine.
- effets indésirables : Albendazole, Antihelminthiques, Diéthylcarbamazine.
- organisation et administration : Services de santé communautaires.
- parasitologie : Sol.
- usage thérapeutique : Albendazole, Antihelminthiques, Diéthylcarbamazine.
- épidémiologie : Filariose lymphatique, Inde.
- Association de médicaments, Facteurs temps, Femelle, Filariose lymphatique, Humains, Lutte contre les moustiques, Participation communautaire.
English descriptors
- KwdEn :
- Albendazole (administration & dosage), Albendazole (adverse effects), Albendazole (therapeutic use), Anthelmintics (administration & dosage), Anthelmintics (adverse effects), Anthelmintics (therapeutic use), Community Health Services (organization & administration), Community Participation, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (adverse effects), Diethylcarbamazine (therapeutic use), Drug Therapy, Combination, Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (prevention & control), Female, Humans, India (epidemiology), Mosquito Control (methods), Soil (parasitology), Time Factors.
- MESH :
- chemical , administration & dosage : Albendazole, Anthelmintics, Diethylcarbamazine.
- chemical , adverse effects : Albendazole, Anthelmintics, Diethylcarbamazine.
- chemical , parasitology : Soil.
- chemical , therapeutic use : Albendazole, Anthelmintics, Diethylcarbamazine.
- epidemiology : Elephantiasis, Filarial, India.
- methods : Mosquito Control.
- organization & administration : Community Health Services.
- prevention & control : Elephantiasis, Filarial.
- Community Participation, Drug Therapy, Combination, Female, Humans, Time Factors.
Abstract
The World Health Assembly in 1997 has targeted the elimination of lymphatic filariasis (LF) by 2020, and in India the goal has been set for the year 2015 by annual single dose mass drug administration (MDA). The role of community empowerment in enhancing the drug compliance and bringing out the function of various methods used to disseminate the information on MDA to the villagers is focused. A longitudinal survey was carried out in nine villages in Tirukoilur block of Villupuram district, Tamil Nadu for filarial infection variables like microfilaraemia, antigenaemia, transmission indices before and after each MDA, to determine the drug impact. Prior to each MDA, health education campaigns with different approaches were carried out with community as the leading player. These IEC approaches were assessed after 4 MDAs for its perception in the community. After four rounds of MDA, there was a significant decline in the filarial infection variables. The microfilaraemia and antigenaemia declined by 59% and 67% respectively. The transmission indices lowered by 89% and 94% (in resting and landing catch of mosquitoes respectively). The decline in these variables, with a drug consumption rate of >80% was achieved due to the effective IEC campaigns prior to each MDA. After 4 MDAs almost 97% of the respondents were aware of lymphatic filariasis. The KAP survey in the rural villages revealed that the dissemination of MDA message through autorickshaw was the most effective, followed by school students' rally. Empowerment of community through the members of women self help groups and school students were observed to be integral to mass drug administration campaigns for the enhancement of drug compliance, thus leading to LF elimination.
PubMed: 20562816
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002A17
- to stream PubMed, to step Curation: 002A17
- to stream PubMed, to step Checkpoint: 002A17
- to stream Ncbi, to step Merge: 003B96
- to stream Ncbi, to step Curation: 003B96
- to stream Ncbi, to step Checkpoint: 003B96
- to stream Main, to step Merge: 005688
- to stream Main, to step Curation: 005640
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of community empowerment in the elimination of lymphatic filariasis in south India.</title><author><name sortKey="Rajendran, R" sort="Rajendran, R" uniqKey="Rajendran R" first="R" last="Rajendran">R. Rajendran</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Research in Medical Entomology (ICMR), 4-Sarojini Street, Chinna Chokkikulam, Madurai-625 002, India. crmeicmr@icmr.org.in</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Centre for Research in Medical Entomology (ICMR), 4-Sarojini Street, Chinna Chokkikulam, Madurai-625 002</wicri:regionArea><wicri:noRegion>Madurai-625 002</wicri:noRegion></affiliation></author><author><name sortKey="Sunish, I P" sort="Sunish, I P" uniqKey="Sunish I" first="I P" last="Sunish">I P Sunish</name></author><author><name sortKey="Munirathinam, A" sort="Munirathinam, A" uniqKey="Munirathinam A" first="A" last="Munirathinam">A. Munirathinam</name></author><author><name sortKey="Ashok Kumar, V" sort="Ashok Kumar, V" uniqKey="Ashok Kumar V" first="V" last="Ashok Kumar">V. Ashok Kumar</name></author><author><name sortKey="Tyagi, B K" sort="Tyagi, B K" uniqKey="Tyagi B" first="B K" last="Tyagi">B K Tyagi</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20562816</idno><idno type="pmid">20562816</idno><idno type="wicri:Area/PubMed/Corpus">002A17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A17</idno><idno type="wicri:Area/PubMed/Curation">002A17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A17</idno><idno type="wicri:Area/PubMed/Checkpoint">002A17</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A17</idno><idno type="wicri:Area/Ncbi/Merge">003B96</idno><idno type="wicri:Area/Ncbi/Curation">003B96</idno><idno type="wicri:Area/Ncbi/Checkpoint">003B96</idno><idno type="wicri:doubleKey">0127-5720:2010:Rajendran R:role:of:community</idno><idno type="wicri:Area/Main/Merge">005688</idno><idno type="wicri:Area/Main/Curation">005640</idno><idno type="wicri:Area/Main/Exploration">005640</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Role of community empowerment in the elimination of lymphatic filariasis in south India.</title><author><name sortKey="Rajendran, R" sort="Rajendran, R" uniqKey="Rajendran R" first="R" last="Rajendran">R. Rajendran</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Research in Medical Entomology (ICMR), 4-Sarojini Street, Chinna Chokkikulam, Madurai-625 002, India. crmeicmr@icmr.org.in</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Centre for Research in Medical Entomology (ICMR), 4-Sarojini Street, Chinna Chokkikulam, Madurai-625 002</wicri:regionArea><wicri:noRegion>Madurai-625 002</wicri:noRegion></affiliation></author><author><name sortKey="Sunish, I P" sort="Sunish, I P" uniqKey="Sunish I" first="I P" last="Sunish">I P Sunish</name></author><author><name sortKey="Munirathinam, A" sort="Munirathinam, A" uniqKey="Munirathinam A" first="A" last="Munirathinam">A. Munirathinam</name></author><author><name sortKey="Ashok Kumar, V" sort="Ashok Kumar, V" uniqKey="Ashok Kumar V" first="V" last="Ashok Kumar">V. Ashok Kumar</name></author><author><name sortKey="Tyagi, B K" sort="Tyagi, B K" uniqKey="Tyagi B" first="B K" last="Tyagi">B K Tyagi</name></author></analytic><series><title level="j">Tropical biomedicine</title><idno type="ISSN">0127-5720</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Albendazole (administration & dosage)</term><term>Albendazole (adverse effects)</term><term>Albendazole (therapeutic use)</term><term>Anthelmintics (administration & dosage)</term><term>Anthelmintics (adverse effects)</term><term>Anthelmintics (therapeutic use)</term><term>Community Health Services (organization & administration)</term><term>Community Participation</term><term>Diethylcarbamazine (administration & dosage)</term><term>Diethylcarbamazine (adverse effects)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Drug Therapy, Combination</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Elephantiasis, Filarial (prevention & control)</term><term>Female</term><term>Humans</term><term>India (epidemiology)</term><term>Mosquito Control (methods)</term><term>Soil (parasitology)</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Albendazole (administration et posologie)</term><term>Albendazole (effets indésirables)</term><term>Albendazole (usage thérapeutique)</term><term>Antihelminthiques (administration et posologie)</term><term>Antihelminthiques (effets indésirables)</term><term>Antihelminthiques (usage thérapeutique)</term><term>Association de médicaments</term><term>Diéthylcarbamazine (administration et posologie)</term><term>Diéthylcarbamazine (effets indésirables)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Facteurs temps</term><term>Femelle</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (épidémiologie)</term><term>Humains</term><term>Inde (épidémiologie)</term><term>Lutte contre les moustiques ()</term><term>Participation communautaire</term><term>Services de santé communautaires (organisation et administration)</term><term>Sol (parasitologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Diethylcarbamazine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Diethylcarbamazine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="parasitology" xml:lang="en"><term>Soil</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Albendazole</term><term>Anthelmintics</term><term>Diethylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Diéthylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Diéthylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>India</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Mosquito Control</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Services de santé communautaires</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Community Health Services</term></keywords><keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr"><term>Sol</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Albendazole</term><term>Antihelminthiques</term><term>Diéthylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Inde</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Community Participation</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term><term>Facteurs temps</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Lutte contre les moustiques</term><term>Participation communautaire</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The World Health Assembly in 1997 has targeted the elimination of lymphatic filariasis (LF) by 2020, and in India the goal has been set for the year 2015 by annual single dose mass drug administration (MDA). The role of community empowerment in enhancing the drug compliance and bringing out the function of various methods used to disseminate the information on MDA to the villagers is focused. A longitudinal survey was carried out in nine villages in Tirukoilur block of Villupuram district, Tamil Nadu for filarial infection variables like microfilaraemia, antigenaemia, transmission indices before and after each MDA, to determine the drug impact. Prior to each MDA, health education campaigns with different approaches were carried out with community as the leading player. These IEC approaches were assessed after 4 MDAs for its perception in the community. After four rounds of MDA, there was a significant decline in the filarial infection variables. The microfilaraemia and antigenaemia declined by 59% and 67% respectively. The transmission indices lowered by 89% and 94% (in resting and landing catch of mosquitoes respectively). The decline in these variables, with a drug consumption rate of >80% was achieved due to the effective IEC campaigns prior to each MDA. After 4 MDAs almost 97% of the respondents were aware of lymphatic filariasis. The KAP survey in the rural villages revealed that the dissemination of MDA message through autorickshaw was the most effective, followed by school students' rally. Empowerment of community through the members of women self help groups and school students were observed to be integral to mass drug administration campaigns for the enhancement of drug compliance, thus leading to LF elimination.</div></front></TEI><affiliations><list><country><li>Inde</li></country></list><tree><noCountry><name sortKey="Ashok Kumar, V" sort="Ashok Kumar, V" uniqKey="Ashok Kumar V" first="V" last="Ashok Kumar">V. Ashok Kumar</name><name sortKey="Munirathinam, A" sort="Munirathinam, A" uniqKey="Munirathinam A" first="A" last="Munirathinam">A. Munirathinam</name><name sortKey="Sunish, I P" sort="Sunish, I P" uniqKey="Sunish I" first="I P" last="Sunish">I P Sunish</name><name sortKey="Tyagi, B K" sort="Tyagi, B K" uniqKey="Tyagi B" first="B K" last="Tyagi">B K Tyagi</name></noCountry><country name="Inde"><noRegion><name sortKey="Rajendran, R" sort="Rajendran, R" uniqKey="Rajendran R" first="R" last="Rajendran">R. Rajendran</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005640 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005640 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20562816
|texte= Role of community empowerment in the elimination of lymphatic filariasis in south India.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20562816" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |